The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The GCC in-vitro diagnostic devices market size reached US$ 1,125 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,486 Million by 2027, exhibiting a growth rate (CAGR) of 4.6% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
In-vitro diagnostics (IVD) refer to the clinical tests conducted on different bodily samples, such as urine, tissue and blood, to detect diseases and infections. These tests are also employed to monitor the health conditions of patients undergoing different treatments and the effectiveness of therapeutic procedures. Various devices can be used individually or in combination with each other for in-vitro diagnosis, including specimen receptacles, calibrators, reagents and control materials. In the GCC countries, IVD devices have gained traction on account of the aging population, the expanding healthcare sector and the establishment of standalone centers, independent diagnostics chains and academic institutes.
The easy access to better diagnostics and healthcare facilities represents the primary factor impelling the growth of the market in the GCC region. This is facilitated by the increasing insurance penetration rate under the Mandatory Health Insurance (MHI) schemes in the GCC countries. Besides this, a large portion of the deaths in the GCC countries is caused due to chronic diseases that are generally associated with lifestyle factors, including tobacco consumption, unhealthy diets and sedentary schedules. Consequently, the growing health consciousness among consumers has led to a significant rise in the number of people seeking diagnostic services at regular intervals to avoid these conditions. Additionally, individuals have increased their medical health spending due to inflating disposable incomes, which has further influenced the market growth. Moreover, the governments of several GCC countries have developed various health awareness programs and strategies. They have also shifted their focus toward promoting specialized care and services and are increasing investments in the purchase of devices used in medical examinations. Other factors, such as the rising number of expatriates and growing investments in healthcare infrastructure, are further driving the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the GCC in-vitro diagnostic devices market report, along with forecasts at the regional and country level from 2022-2027. Our report has categorized the market based on end-user and application.
Breakup by End-user:
At present, in-vitro diagnostic devices are majorly used in hospital-based centers.
Breakup by Application:
Presently, infectious diseases exhibit a clear dominance in the market.
Region-wise, Saudi Arabia holds the leading position in the market.
The competitive landscape of the market has been examined in the report with the detailed profiles of the key players operating in the industry.
|Base Year of the Analysis||2021|
|Segment Coverage||End User, Application, Country|
|Region Covered||Saudi Arabia, United Arab Emirates, Qatar, Oman, Kuwait, Bahrain|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at